MM
Mugil Murya
About Mugil Murya
Data last updated:
Mugil Murya has 7 years in corporate governance. Holds Director role. Currently with 3 companies, including Proclin Research Private Limited and Sugariq Nutratech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Proclin Research Private Limited at ₹2.29 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 May 2019 | 2019 | ₹2.29 Cr (FY 2024) | Active | |
| Director | 12 Jan 2026 | 2026 | – | Active | |
| Director | 14 Oct 2024 | 2024 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mugil Murya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mugil Murya
Mugil Murya has 7 years in corporate governance. Holds Director role. Currently with 3 companies, including Proclin Research Private Limited and Sugariq Nutratech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Proclin Research Private Limited at ₹2.29 Cr (FY 2024).
Mugil Murya is associated with 3 companies as Director, including Proclin Research Private Limited (₹2.29 Cr), Sugariq Nutratech Private Limited, Proclin Institute Of Medical Research Private Limited.
Mugil Murya has expertise in General Business, Technology.
Mugil Murya has 7 years in corporate governance.
By reported revenue, the largest current company of Mugil Murya is Proclin Research Private Limited, with revenue of ₹2.29 Cr (FY 2024).
Mugil Murya currently holds positions at 3 companies: Proclin Research Private Limited (₹2.29 Cr), Sugariq Nutratech Private Limited, Proclin Institute Of Medical Research Private Limited.